Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06861309 · ClinicalTrials.gov registry record
Placental Imaging Techniques
A clinical trial of Pregnancy and Preeclampsia, sponsored by Carilion Clinic.
- Recruiting
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT06861309 is a study of Pregnancy and Preeclampsia that is actively recruiting participants, run by Carilion Clinic. The registered enrollment target is 60 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06861309, a study of Pregnancy and Preeclampsia, is actively recruiting participants, sponsored by Carilion Clinic.
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proof-of-concept, case-control, clinical trial is to evaluate the efficacy of using two newer ultrasound technologies, quantitative ultrasound (QUS) and ultrafast power Doppler imaging (uPDI), to evaluate the health of the placenta, visualize blood flow through the placental vasculature by color Doppler imaging in singleton pregnancies with and without fetal growth restriction (FGR). * Our primary objective is to investigate the ability of using these ultrasound technologies to distinguish healthy pregnancies from those affected by FGR, a condition characterized by a fetal weight below the 10th percentile for the gestational age or abdominal circumference of the pregnancy. * Secondary aims include longitudinal evaluation of differences in QUS and uPDI imaging over gestation and changes in these measures with evolution of utero-placental insufficiency including with the development of abnormal umbilical-artery Doppler testing, diagnosis of severe FGR, identification of stillbirth, and detection of preeclampsia or preterm birth. Investigators will compare QUS/uPDI imaging and values in pregnancies determined to be healthy by approved, standard-of-care growth ultrasounds to those diagnosed with FGR. Participants will receive research ultrasounds with the experimental Verasonics Vantage 256 system (Verasonics, Inc, Kirkland, WA) utilizing uPDI/QUS every three weeks following their routine growth ultrasound evaluation until delivery. Demographic, obstetric, and delivery-related information, as well as portions of subjects' past medical history will be utilized by researchers to further contextualize imaging and variables gathered during the research ultrasounds.
Conditions Studied
Interventions
- DEVICE ultrafast power Doppler imaging (uPDI) / quantitative ultrasound (QUS)
Study Locations (1)
Virginia
- Carilion Clinic Maternal Fetal Medicine - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-04-23 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06861309
The ClinicalTrials.gov registry entry for NCT06861309 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which ultrafast power Doppler imaging (uPDI) / quantitative ultrasound (QUS) is the first listed.
NCT06861309 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06861309 about?
NCT06861309 is a clinical study titled "Placental Imaging Techniques". The goal of this proof-of-concept, case-control, clinical trial is to evaluate the efficacy of using two newer ultrasound technologies, quantitative ultrasound (QUS) and ultrafast power Doppler imaging (uPDI), to evaluate the health of the placenta, visualize blood flow through the placental vascula...
What is the current status of trial NCT06861309?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-04-23. Estimated completion is 2026-11.
What conditions does trial NCT06861309 study?
This clinical trial studies the following conditions: Pregnancy, Preeclampsia, Pregnancy Complications, Ultrasound, Placental Insufficiency.
What interventions are being tested in trial NCT06861309?
The interventions under investigation include: ultrafast power Doppler imaging (uPDI) / quantitative ultrasound (QUS) (DEVICE).
Who is sponsoring clinical trial NCT06861309?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06861309 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.